HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Peter J M Valk Selected Research

Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase)

8/2013High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Peter J M Valk Research Topics

Disease

24Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2015 - 12/2005
6Leukemia
12/2012 - 10/2002
5Neoplasms (Cancer)
06/2013 - 05/2008
4Hematologic Neoplasms (Hematological Malignancy)
06/2013 - 02/2002
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2013 - 06/2010
2BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
06/2015 - 05/2015
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
06/2015
1Thrombosis (Thrombus)
06/2015
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2015
1Refractory Anemia
05/2014
1Refractory Anemia with Excess of Blasts (RAEM)
05/2014
1Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase)
08/2013
1Acute Promyelocytic Leukemia
01/2011
1Chromosome Aberrations (Chromosome Abnormalities)
04/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2006
1Lymphoma (Lymphomas)
05/2005
1Myeloid Leukemia (Leukemia, Myelocytic)
04/2002

Drug/Important Bio-Agent (IBA)

7Messenger RNA (mRNA)IBA
05/2014 - 04/2002
4Transcription Factors (Transcription Factor)IBA
11/2013 - 10/2004
3imatinib (Gleevec)FDA Link
08/2013 - 06/2010
3CCAAT-Enhancer-Binding Protein-alphaIBA
05/2013 - 03/2009
3nucleophosminIBA
04/2013 - 12/2005
3DNA (Deoxyribonucleic Acid)IBA
01/2011 - 10/2002
2INCB018424IBA
06/2015 - 05/2015
2RNA (Ribonucleic Acid)IBA
01/2015 - 06/2013
2Complementary DNA (cDNA)IBA
05/2014 - 04/2002
2Cytarabine (Cytosar-U)FDA LinkGeneric
08/2013 - 06/2010
2Severe congenital neutropeniaIBA
05/2013 - 05/2012
2Core Binding Factors (Core-Binding Factor)IBA
03/2011 - 10/2008
2CB2 Cannabinoid ReceptorIBA
04/2002 - 02/2002
1CalreticulinIBA
06/2015
1Lysine (L-Lysine)FDA Link
01/2015
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2015
1Mercaptoethanol (2 Mercaptoethanol)IBA
06/2013
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
05/2013
1Differentiation AntigensIBA
12/2012
1Phosphotransferases (Kinase)IBA
07/2012
1tyrosine receptor (receptor, tyrosine)IBA
07/2012
1HexokinaseIBA
05/2012
1nuclear pore complex protein 98IBA
09/2011
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
09/2011
1CCAAT-Enhancer-Binding ProteinsIBA
03/2011
1A-Form DNA (A-DNA)IBA
01/2011
1PeroxiredoxinsIBA
01/2011
1alpha-hydroxyglutarateIBA
12/2010
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
09/2010
1retinoic acid receptor alphaIBA
06/2010
1promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
06/2010
1monosomy Chromosome 7IBA
04/2010
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
11/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2009
1Tryptophan (L-Tryptophan)FDA Link
12/2008
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
12/2008
1MicroRNAs (MicroRNA)IBA
05/2008
1proto-oncogene protein Spi-1IBA
11/2006
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2006
1glucose-regulated proteinsIBA
05/2005
1nucleotidaseIBA
05/2005
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
07/2012 - 11/2009
1Transplantation (Transplant Recipients)
06/2010
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2010